These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 35288801)
1. Enhanced Intramuscular Bioavailability of Cannabidiol Using Nanocrystals: Formulation, In Vitro Appraisal, and Pharmacokinetics. Fu X; Xu S; Li Z; Chen K; Fan H; Wang Y; Xie Z; Kou L; Zhang S AAPS PharmSciTech; 2022 Mar; 23(3):85. PubMed ID: 35288801 [TBL] [Abstract][Full Text] [Related]
2. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability. Jain S; Reddy VA; Arora S; Patel K Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488 [TBL] [Abstract][Full Text] [Related]
3. Development and pharmacokinetic evaluation of a self-nanoemulsifying drug delivery system for the oral delivery of cannabidiol. Kok LY; Bannigan P; Sanaee F; Evans JC; Dunne M; Regenold M; Ahmed L; Dubins D; Allen C Eur J Pharm Sci; 2022 Jan; 168():106058. PubMed ID: 34763088 [TBL] [Abstract][Full Text] [Related]
4. Nanosuspension-Loaded Dissolving Microneedle Patches for Enhanced Transdermal Delivery of a Highly Lipophilic Cannabidiol. Cheng A; Zhang S; Meng F; Xing M; Liu H; Yang G; Gao Y Int J Nanomedicine; 2024; 19():4061-4079. PubMed ID: 38736651 [TBL] [Abstract][Full Text] [Related]
5. Key Transdermal Patch Using Cannabidiol-Loaded Nanocarriers with Better Pharmacokinetics in vivo. Chu PC; Liao MH; Liu MG; Li CZ; Lai PS Int J Nanomedicine; 2024; 19():4321-4337. PubMed ID: 38770103 [TBL] [Abstract][Full Text] [Related]
6. Improved oral bioavailability for lutein by nanocrystal technology: formulation development, in vitro and in vivo evaluation. Chang D; Ma Y; Cao G; Wang J; Zhang X; Feng J; Wang W Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1018-1024. PubMed ID: 28749189 [TBL] [Abstract][Full Text] [Related]
7. The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model. Cherniakov I; Izgelov D; Domb AJ; Hoffman A Eur J Pharm Sci; 2017 Nov; 109():21-30. PubMed ID: 28736128 [TBL] [Abstract][Full Text] [Related]
8. Formulation, optimization, and in vitro-in vivo evaluation of olmesartan medoxomil nanocrystals. Jain S; Patel K; Arora S; Reddy VA; Dora CP Drug Deliv Transl Res; 2017 Apr; 7(2):292-303. PubMed ID: 28116656 [TBL] [Abstract][Full Text] [Related]
9. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability. Ige PP; Baria RK; Gattani SG Colloids Surf B Biointerfaces; 2013 Aug; 108():366-73. PubMed ID: 23602990 [TBL] [Abstract][Full Text] [Related]
10. Preparation and Evaluation of Diosgenin Nanocrystals to Improve Oral Bioavailability. Liu CZ; Chang JH; Zhang L; Xue HF; Liu XG; Liu P; Fu Q AAPS PharmSciTech; 2017 Aug; 18(6):2067-2076. PubMed ID: 27995466 [TBL] [Abstract][Full Text] [Related]
11. Appraisal of Felodipine Nanocrystals for Solubility Enhancement and Pharmacodynamic Parameters on Cadmium Chloride Induced Hypertension in Rats. Maurya P; Pandey P; Singh S; Sonkar A; Singh S; Saraf SA Curr Drug Deliv; 2022; 19(5):625-634. PubMed ID: 34325637 [TBL] [Abstract][Full Text] [Related]
12. Enhanced oral bioavailability of cannabidiol by flexible zein nanoparticles: Nie Y; Kong Y; Peng J; Sun J; Fan B Front Nutr; 2024; 11():1431620. PubMed ID: 39086540 [TBL] [Abstract][Full Text] [Related]
13. Poly(ethylene glycol)-b-poly(epsilon-caprolactone) nanoparticles as a platform for the improved oral delivery of cannabidiol. Shreiber-Livne I; Sulimani L; Shapira A; Procaccia S; Meiri D; Sosnik A Drug Deliv Transl Res; 2023 Dec; 13(12):3192-3203. PubMed ID: 37341881 [TBL] [Abstract][Full Text] [Related]
14. Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine: Preparation, characterization, and in vivo evaluation. Alshweiat A; Csóka I; Tömösi F; Janáky T; Kovács A; Gáspár R; Sztojkov-Ivanov A; Ducza E; Márki Á; Szabó-Révész P; Ambrus R Int J Pharm; 2020 Apr; 579():119166. PubMed ID: 32084574 [TBL] [Abstract][Full Text] [Related]
15. Characterization and evaluation in vivo of baicalin-nanocrystals prepared by an ultrasonic-homogenization-fluid bed drying method. Shi-Ying J; Jin H; Shi-Xiao J; Qing-Yuan L; Jin-Xia B; Chen HG; Rui-Sheng L; Wei W; Hai-Long Y Chin J Nat Med; 2014 Jan; 12(1):71-80. PubMed ID: 24484600 [TBL] [Abstract][Full Text] [Related]
16. Development of an Caggiano NJ; Wilson BK; Priestley RD; Prud'homme RK Mol Pharm; 2022 May; 19(5):1515-1525. PubMed ID: 35412842 [TBL] [Abstract][Full Text] [Related]
17. Development of cannabidiol nanoemulsion for direct nose to brain delivery: statistical optimization, Ahmed B; Rizwanullah M; Mir SR; Akhtar MS; Amin S Biomed Mater; 2022 Sep; 17(6):. PubMed ID: 36108625 [TBL] [Abstract][Full Text] [Related]
18. Improved Bioavailability with Dry Powder Cannabidiol Inhalation: A Phase 1 Clinical Study. Devinsky O; Kraft K; Rusch L; Fein M; Leone-Bay A J Pharm Sci; 2021 Dec; 110(12):3946-3952. PubMed ID: 34400185 [TBL] [Abstract][Full Text] [Related]
19. Development of a Novel Nano-emulsion Formulation to Improve Intestinal Absorption of Cannabidiol. Nakano Y; Tajima M; Sugiyama E; Sato VH; Sato H Med Cannabis Cannabinoids; 2019 Sep; 2(1):35-42. PubMed ID: 34676332 [TBL] [Abstract][Full Text] [Related]
20. A Novel Self-Emulsifying Drug Delivery System (SEDDS) Based on VESIsorb Knaub K; Sartorius T; Dharsono T; Wacker R; Wilhelm M; Schön C Molecules; 2019 Aug; 24(16):. PubMed ID: 31426272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]